Cargando…

Functional animal proteins activate mTOR and bind pro-inflammatory compounds

Detalles Bibliográficos
Autores principales:	Detzel, Christopher J, Fleming, Michael Q, Warner, Christopher D, Henderson, Abigail L, Weaver, Eric M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595508/ http://dx.doi.org/10.1186/1550-2783-12-S1-P35

Ejemplares similares

Bovine Immunoglobulin/Protein Isolate Binds Pro-Inflammatory Bacterial Compounds and Prevents Immune Activation in an Intestinal Co-Culture Model
por: Detzel, Christopher J., et al.
Publicado: (2015)

Post-prandial amino acid and leucine responses to serum albumin concentrate compared to whey protein concentrate in healthy subjects
por: Weaver, Eric M, et al.
Publicado: (2014)

Soy-derived Phosphatidic Acid, Lysophosphatidic acid and Phosphatidylserine are sufficient to induce an increase in mTOR signaling
por: Gundermann, David M, et al.
Publicado: (2013)

Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer’s disease rats
por: Wang, Xu, et al.
Publicado: (2016)

Interleukin-15 potentiates human natural killer cells to resist tumor-induced suppression through mTOR-regulated metabolic control
por: Lundqvist, Andreas, et al.
Publicado: (2015)

AKT/TSC/mTOR activation by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: novel therapeutic targets for the treatment of Kaposi's sarcoma
por: Montaner, S, et al.
Publicado: (2009)

A comparison of the effects of ursolic acid and l-leucine supplementation on IGF-1 receptor and AKT-mTOR signaling in response to resistance exercise in trained men
por: Church, David, et al.
Publicado: (2014)

Interleukin-33 in asthma: insights into pro-inflammatory roles of airway structural cells
por: Préfontaine, D, et al.
Publicado: (2010)

The effects of oral BCAAs and leucine supplementation combined with an acute lower-body resistance exercise on mTOR and 4E-BP1 activation in humans: preliminary findings
por: La Bounty, Paul, et al.
Publicado: (2008)

Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
por: Dittmer, Dirk P, et al.
Publicado: (2012)

The phosphatidylinositol-3 kinase/mTOR pathway: new agents
por: Arteaga, CL
Publicado: (2011)

mTOR inhibitors in cancer therapy
por: Xie, Jianling, et al.
Publicado: (2016)

What UK pre-hospital providers use intranasal analgesia? A survey of its current and planned use by air ambulance services in the United Kingdom
por: Pascoe, Craig, et al.
Publicado: (2014)

All PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells
por: Gamper, Christopher J., et al.
Publicado: (2012)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

mTOR sustains inflammatory response in celiac disease
por: Sedda, S., et al.
Publicado: (2020)

Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway
por: Addie, Ruben D., et al.
Publicado: (2019)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Association of pro-inflammatory cytokine gene polymorphisms with schizophrenia in South Indian population
por: Srinivas, Lekshmy, et al.
Publicado: (2014)

Melanoma cells with acquired resistance to dabrafenib display changes in miRNA expression pattern and respond to this drug with an increase of invasiveness, which is abrogated by inhibition of NF-κB or the PI3K/mTOR signalling pathway
por: Caporali, Simona, et al.
Publicado: (2015)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity
por: Mota-Martorell, Natalia, et al.
Publicado: (2022)

PRO 2000, a broadly active anti-HIV sulfonated compound, inhibits viral entry by multiple mechanisms
por: Huskens, Dana, et al.
Publicado: (2010)

Clinical severity and local inflammatory responses in animal models of sepsis
por: Saeed, S, et al.
Publicado: (2010)

mTOR's role in ageing: protein synthesis or autophagy?
por: Hands, Sarah L., et al.
Publicado: (2009)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

Natural antibodies and antiphospholipid antibodies bind to injured tissues, activate complement and cause tissue damage
por: Tsokos, G, et al.
Publicado: (2003)

Predicting the binding type of compounds on the 4 adenosine receptors using proteochemometric models
por: van den Hoven, Olaf, et al.
Publicado: (2010)

Proteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to mTOR
por: Yore, Mark M., et al.
Publicado: (2011)

mTOR kinase structure, mechanism and regulation by the rapamycin-binding domain
por: Yang, Haijuan, et al.
Publicado: (2013)

Converging evidence for the pro-inflammatory role of p-glycoprotein in Th2 polarized chronic rhinosinusitis endotypes
por: Bleier, Benjamin
Publicado: (2015)

Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment
por: Zappasodi, Roberta, et al.
Publicado: (2014)

Exploring mTOR inhibition as treatment for mitochondrial disease
por: Sage‐Schwaede, Abigail, et al.
Publicado: (2019)

mTOR and lysosome regulation
por: Puertollano, Rosa
Publicado: (2014)

mTOR, autophagy, and reprogramming
por: Tang, Bor Luen
Publicado: (2014)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0vuh4j2fgfts6prllq3i06n94s